These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21823282)

  • 21. Double blind trial of trimebutine in the irritable bowel syndrome.
    Fielding JF
    Ir Med J; 1980 Oct; 73(10):377-9. PubMed ID: 7000730
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mechanism of action of trimebutine maleate on gastro-colic reflex in patients with irritable bowel syndrome].
    Matsue T; Yamato S; Umeda N
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):89-92. PubMed ID: 2273694
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative analysis of efficiency of the estimation of quality of life in patients with irritable bowel syndrome using questionnaires IBS-QOL and index BEST].
    Pilipenko VI; Isakov VA
    Eksp Klin Gastroenterol; 2008; (6):4-8. PubMed ID: 19334419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.
    Johnston JM; Kurtz CB; Macdougall JE; Lavins BJ; Currie MG; Fitch DA; O'Dea C; Baird M; Lembo AJ
    Gastroenterology; 2010 Dec; 139(6):1877-1886.e2. PubMed ID: 20801122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study.
    Corinaldesi R; Stanghellini V; Cremon C; Gargano L; Cogliandro RF; De Giorgio R; Bartesaghi G; Canovi B; Barbara G
    Aliment Pharmacol Ther; 2009 Aug; 30(3):245-52. PubMed ID: 19438846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of Debridat in treating the irritable bowel syndrome].
    Parfenov AI
    Voen Med Zh; 1996 May; 317(5):37-8. PubMed ID: 8754091
    [No Abstract]   [Full Text] [Related]  

  • 27. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Forty cases of irritable bowel syndrome in diarrhea type treated with dog days moxibustion].
    Song FX; Zhang RH
    Zhongguo Zhen Jiu; 2011 Feb; 31(2):153-4. PubMed ID: 21442822
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
    Dolin BJ
    Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
    Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anatomy of the placebo effect. Sham acupuncture in IBS shows three components of the placebo effect].
    Nilsson G
    Lakartidningen; 2008 Dec 10-16; 105(50):3632-3. PubMed ID: 19177927
    [No Abstract]   [Full Text] [Related]  

  • 32. Patients with irritable bowel syndrome in primary care appear not to be heavy healthcare utilizers.
    Faresjö A; Grodzinsky E; Foldevi M; Johansson S; Wallander MA
    Aliment Pharmacol Ther; 2006 Mar; 23(6):807-14. PubMed ID: 16556183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Observation on therapeutic effect of acupuncture on restless legs syndrome].
    Wu YH; Sun CL; Wu D; Huang YY; Chi CM
    Zhongguo Zhen Jiu; 2008 Jan; 28(1):27-9. PubMed ID: 18257184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrinological effects of acupuncture treatment in patients with irritable bowel syndrome.
    Schneider A; Weiland C; Enck P; Joos S; Streitberger K; Maser-Gluth C; Zipfel S; Bagheri S; Herzog W; Friederich HC
    Complement Ther Med; 2007 Dec; 15(4):255-63. PubMed ID: 18054727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome.
    Hong YS; Hong KS; Park MH; Ahn YT; Lee JH; Huh CS; Lee J; Kim IK; Hwang GS; Kim JS
    J Clin Gastroenterol; 2011; 45(5):415-25. PubMed ID: 21494186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of irritable bowel syndrome in Italian rural and urban areas.
    Usai P; Manca R; Lai MA; Russo L; Boi MF; Ibba I; Giolitto G; Cuomo R
    Eur J Intern Med; 2010 Aug; 21(4):324-6. PubMed ID: 20603045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Irritable bowel syndrome in the elderly].
    Sasaki D; Fukushi T; Sato K; Takimoto M; Nakahata H; Munakata A
    Nihon Rinsho; 2006 Aug; 64(8):1516-20. PubMed ID: 16898624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care.
    Reme SE; Kennedy T; Jones R; Darnley S; Chalder T
    J Psychosom Res; 2010 Apr; 68(4):385-8. PubMed ID: 20307706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Frequency of celiac disease and irritable bowel syndrome coexistance and its influence on the disease course].
    Zwolińska-Wcisło M; Galicka-Latała D; Rozpondek P; Rudnicka-Sosin L; Mach T
    Przegl Lek; 2009; 66(3):126-9. PubMed ID: 19689036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.